HNN3.0
Register
Register
Register

Pharmalysis AI

Company (SME)

Istanbul, Türkiye
5 profile visits

About

Pharmalysis is a proactive decision-support ecosystem designed to eliminate preventable medication errors, specifically focusing on the challenges of polypharmacy in the elderly. By utilizing advanced Natural Language Processing (NLP), Pharmalysis screens clinical data in real-time to identify high-risk interactions between medications, nutrition, and supplements. It transforms pharmacovigilance from a reactive process into a predictive safety shield, ensuring 'Medication Without Harm' for the most vulnerable patient populations

Representatives

Professor of Otolaryngology, Head and Neck Surgery,

Pharmalysis AI

Marketplace (1)

  • Project cooperation

    : AI-Driven Pharmacovigilance for Geriatric Polypharmacy Management

    An AI-driven safety ecosystem preventing geriatric medication errors by screening drug, food, and supplement risks in real-time.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    Professor of Otolaryngology, Head and Neck Surgery, at Pharmalysis AI

    Istanbul, Türkiye